Rapid Radiographic and Clinical Improvement After Treatment of a MET-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor-Reference-Cited by-同舟云学术

Rapid Radiographic and Clinical Improvement After Treatment of a MET-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor

Published:2012-01-20 Issue:3 Volume:30 Page:e30-e33
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Chi Andrew S.¹,Batchelor Tracy T.¹,Kwak Eunice L.¹,Clark Jeffrey W.¹,Wang Daphne L.¹,Wilner Keith D.²,Louis David N.¹,Iafrate A. John¹

Affiliation:

1. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA

2. Pfizer, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.4586

Reference30 articles.

1. Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab

4. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Synopsis of Biomarkers in Glioblastoma: Past and Present;Current Issues in Molecular Biology;2024-07-03

2. Recent in vitro models and tissue engineering strategies to study glioblastoma;Biotech Studies;2024-06-30

3. The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy;Pharmaceuticals;2024-03-30

4. Aberrant MET Receptor Tyrosine Kinase Signaling in Glioblastoma: Targeted Therapy and Future Directions;Cells;2024-01-25

5. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery;Pharmaceutics;2022-12-24